The future of oncology: Redefining the 'new normal' in a pandemic-adjacent world

Disruptions from the COVID-19 pandemic touched all dimensions of oncology, from diagnostic screenings to treatment decisions to cancer programs to clinical trials. Now, healthcare organizations are making use of the lessons learned from the pandemic to shape the future of cancer care and how it is delivered.

Seven oncology leaders from across the U.S. recently participated in a roundtable sponsored by Elsevier and hosted by Becker's Hospital Review to discuss how COVID-19 reshaped the oncology field and how they are preparing for a pandemic-adjacent future. Download the two-page report to read the main insights from the discussion.

Key learning points:
  • The changes organizations are making to prioritize cancer care delivery
  • The unique role of health educators and support staff
  • What future oncology care models will incorporate
  • The outlook on the cost of oncology drugs


Please fill out the form to download the whitepaper.